Some of the rarer skin conditions associated with Crohns disease include acrodermatitis enteropathica and epidermolysis ...

Find out about the early symptoms of Crohn’s disease, to detect it sooner and manage it better. Learn to pay attention to ...

Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

Women with inflammatory bowel disease (IBD) are three times more likely to forgo having children than people without the ...

Animator David Soren turns his experience with Crohn’s disease into a powerful middle-grade story that shows how creativity ...

(IN BRIEF) Sandoz has announced the US availability of TYRUKO® (natalizumab-sztn), the first FDA-approved biosimilar to Tysabri® for treating relapsing forms of multiple sclerosis and Crohn’s disease.

Thanks to COVID-era discussions, the 2023 coverage of a Delta passenger who had diarrhea in their seat (I cannot imagine), ...

President Donald Trump's administration could be looking to make major changes to the eligibility of those receiving disability benefits, according to people familiar with the plans as reported by The ...

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Kinsley Kilpatrick put on a convincing show. During visits to Atlanta VA ...

Several major advances in Crohn's disease have marked 2025, including two new FDA-approved therapies, emerging biologics that target novel pathways, and the first global standards for managing ...